HAM

HHR Asset Management Portfolio holdings

AUM $552M
This Quarter Return
+17.48%
1 Year Return
-15.61%
3 Year Return
+76.29%
5 Year Return
+156.95%
10 Year Return
–
AUM
$1.01B
AUM Growth
+$1.01B
Cap. Flow
-$179M
Cap. Flow %
-17.81%
Top 10 Hldgs %
47.12%
Holding
39
New
1
Increased
9
Reduced
26
Closed
3

Top Buys

1
HEI icon
HEICO
HEI
$18.6M
2
HCAT icon
Health Catalyst
HCAT
$15.1M
3
ALGN icon
Align Technology
ALGN
$9.1M
4
SBUX icon
Starbucks
SBUX
$3.02M
5
FIVE icon
Five Below
FIVE
$2.5M

Top Sells

1
BABA icon
Alibaba
BABA
$44.4M
2
RH icon
RH
RH
$22.9M
3
CRM icon
Salesforce
CRM
$20.3M
4
BL icon
BlackLine
BL
$20.1M
5
JD icon
JD.com
JD
$19.5M

Sector Composition

1 Consumer Discretionary 39.5%
2 Communication Services 20.91%
3 Technology 20.86%
4 Financials 9.14%
5 Healthcare 5.03%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PFPT
26
DELISTED
Proofpoint, Inc.
PFPT
$16.4M 1.63% 155,577 -9,280 -6% -$980K
HCAT icon
27
Health Catalyst
HCAT
$239M
$15.1M 1.5% +412,423 New +$15.1M
CRSP icon
28
CRISPR Therapeutics
CRSP
$4.71B
$3.98M 0.4% 47,630 -3,740 -7% -$313K
ALLO icon
29
Allogene Therapeutics
ALLO
$251M
$2.47M 0.25% 65,510 -3,730 -5% -$141K
EDIT icon
30
Editas Medicine
EDIT
$231M
$1.91M 0.19% 68,060 -3,880 -5% -$109K
SGMO icon
31
Sangamo Therapeutics
SGMO
$157M
$1.32M 0.13% 139,760 -7,960 -5% -$75.2K
MGTX icon
32
MeiraGTx Holdings
MGTX
$587M
$1.25M 0.12% 94,664 -5,390 -5% -$71.3K
VYGR icon
33
Voyager Therapeutics
VYGR
$186M
$896K 0.09% 83,918 -4,780 -5% -$51K
RGNX icon
34
Regenxbio
RGNX
$451M
$857K 0.09% 31,130 -1,770 -5% -$48.7K
QTTB icon
35
Q32 Bio
QTTB
$20.9M
$670K 0.07% 62,620 -3,570 -5% -$38.2K
BLUE
36
DELISTED
bluebird bio
BLUE
$604K 0.06% 11,210 -640 -5% -$34.5K
BABA icon
37
Alibaba
BABA
$322B
– – -205,690 Closed -$44.4M
BL icon
38
BlackLine
BL
$3.36B
– – -242,491 Closed -$20.1M
JD icon
39
JD.com
JD
$44.1B
– – -323,772 Closed -$19.5M
1
2